drugset / Trial / NCT07473167
Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients
NaSingle-groupOpen-labelTreatment
Summary
This is a multi-center, phase I/II study to determine the safety and efficacy of TC011(CD19 Targeted CAR-T) in adult patients with relapsed or refractory large B-cell non -hodgkin lymphoma.
Timeline
- Start
- 2023-08-03
- Primary completion
- 2028-02-11
- Completion
- 2028-03-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TC011 | Cell therapy | — | — |